Huma Therapeutics Stock

Huma provides a digital health platform used for predictive care and research.

Sign up today and learn more about Huma Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Huma Therapeutics Stock

Huma is a global health technology company that provides a modular platform to support digital 'hospitals at home' across different disease areas. Its platform combines predictive algorithms, digital biomarkers, and real-world data to advance proactive, predictive care and research. The company was founded in 2011 and is headquartered in London, England.

Funding History

March 2021$90.9M


Co-founder & CEO

Dan Vahdat

Co-founder and Executive Director

Rich Khatib

SVP Business Development, US

Paul Costello

Life Sciences Partnerships Manager

Emily Deacon

Product Design Lead

Nicholas O'Donnell-Hoare

Head of Healthcare

Jonathan Gledhill

Talent Partner - Technology and Product

Adam Jones

Board Member

Claudia Suessmuth-Dyckerhoff

Senior Vice President

Alex Senemar


Shayan Zadeh

Board Member

Rt Hon Alan Milburn


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: